Melatonin in cancer treatment

Elke De Wolf; Stefania Milazzo; Karen Pilkington; Jian Ping Liu; Marcel Zwahlen; Markus Horneber

doi:10.1002/14651858.CD010145

Melatonin in cancer treatment

Elke De Wolf, Stefania Milazzo, Karen Pilkington, Jian Ping Liu, Marcel Zwahlen, Markus Horneber

University of Westminster

Research output: Contribution to journal › Article › peer-review

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the efficacy and tolerability of melatonin for the treatment of cancer patients.

Original language	English
Article number	CD010145
Journal	Cochrane Database of Systematic Reviews
Volume	2012
Issue number	10
DOIs	https://doi.org/10.1002/14651858.CD010145
Publication status	Early online - 17 Oct 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/14651858.CD010145

http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010145/full

Cite this

@article{6b57d9bce08f49aebd257d33a1dfeca1,

title = "Melatonin in cancer treatment",

abstract = "This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the efficacy and tolerability of melatonin for the treatment of cancer patients.",

author = "{De Wolf}, Elke and Stefania Milazzo and Karen Pilkington and Liu, {Jian Ping} and Marcel Zwahlen and Markus Horneber",

year = "2012",

month = oct,

day = "17",

doi = "10.1002/14651858.CD010145",

language = "English",

volume = "2012",

journal = "Cochrane Database of Systematic Reviews",

issn = "1469-493X",

publisher = "John Wiley and Sons Ltd",

number = "10",

}

TY - JOUR

T1 - Melatonin in cancer treatment

AU - De Wolf, Elke

AU - Milazzo, Stefania

AU - Pilkington, Karen

AU - Liu, Jian Ping

AU - Zwahlen, Marcel

AU - Horneber, Markus

PY - 2012/10/17

Y1 - 2012/10/17

N2 - This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the efficacy and tolerability of melatonin for the treatment of cancer patients.

AB - This is the protocol for a review and there is no abstract. The objectives are as follows:To determine the efficacy and tolerability of melatonin for the treatment of cancer patients.

U2 - 10.1002/14651858.CD010145

DO - 10.1002/14651858.CD010145

M3 - Article

SN - 1469-493X

VL - 2012

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 10

M1 - CD010145

ER -

Melatonin in cancer treatment

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this